NOX 1.52% 6.7¢ noxopharm limited

St Vincent’s Hospital LUPIN Study PR, page-2

  1. 1,021 Posts.
    lightbulb Created with Sketch. 38
    Indeed this is really good early news. Even this statement was quite impressive "with 3 of the 4 patients showing a fall in PSA levels of between 75-85%". Yes it is a small group and a bit early to get excited but it is hard to contain that excitement.

    Also we should hear more about CEP-1 trial. The final patient scan should be done this month. Perhaps in May we can get an update.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.